Cargando…
The time option of IVIG treatment is associated with therapeutic responsiveness and coronary artery abnormalities but not with clinical classification in the acute episode of Kawasaki disease
BACKGROUND: In the last decade, incomplete Kawasaki disease (KD), intravenous immunoglobulin (IVIG) non-response and coronary artery abnormalities (CAA) have experienced the increasing trends in China. In addition, the enhancement of pediatricians’ awareness may also raise the diagnostic rate of inc...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668082/ https://www.ncbi.nlm.nih.gov/pubmed/31366406 http://dx.doi.org/10.1186/s12969-019-0352-3 |
_version_ | 1783440152167710720 |
---|---|
author | Samadli, Sama Liu, Fei Fei Mammadov, Goshgar Wang, Jing Jing Liu, Hui Hui Wu, Yang Fang Luo, Huang Huang Wu, Yue Chen, Wei Xia Zhang, Dong Dong Wei, Wei Hu, Peng |
author_facet | Samadli, Sama Liu, Fei Fei Mammadov, Goshgar Wang, Jing Jing Liu, Hui Hui Wu, Yang Fang Luo, Huang Huang Wu, Yue Chen, Wei Xia Zhang, Dong Dong Wei, Wei Hu, Peng |
author_sort | Samadli, Sama |
collection | PubMed |
description | BACKGROUND: In the last decade, incomplete Kawasaki disease (KD), intravenous immunoglobulin (IVIG) non-response and coronary artery abnormalities (CAA) have experienced the increasing trends in China. In addition, the enhancement of pediatricians’ awareness may also raise the diagnostic rate of incomplete KD and stimulate more aggressive initial therapy in the acute episode of KD. Given this background, we hypothesize that the time option of IVIG treatment should be in parallel with peak time of systemic inflammation; either earlier or later IVIG treatment may affect the clinical classification, therapeutic responsiveness and CAA occurrence in KD patients. Therefore, the major objective of the present study is to identify whether the time option of IVIG treatment could be associated with the clinical classification, therapeutic responsiveness and CAA occurrence in the acute episode of KD. MATERIALS AND METHODS: A total of 153 children with KD were recruited between July 2015 and May 2018. All patients received the standard therapy of KD, including a single infusion of IVIG (2 g/kg) and aspirin (30–50 mg/kg/d). Blood samples were collected from all subjects within 24 h pre-IVIG treatment, respectively. Echocardiography was performed during the period from 2 days to 14 days after IVIG treatment. RESULTS: (1) The clinical classification presented no significant heterogenicity among different treatment time (x(2) = 1.59, p > 0.05) (2) Eleven KD patients resisted to IVIG treatment and 7 of them (63.60%) received the initial IVIG dose on day 5 and 6. (3) The distribution of CAA onset was subjected to a significant difference according to timing option of IVIG treatment (x(2) = 11.94, p < 0.05). CONCLUSIONS: The time option of IVIG treatment is associated with therapeutic responsiveness and CAA but not with clinical classification in the acute episode of KD. |
format | Online Article Text |
id | pubmed-6668082 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-66680822019-08-05 The time option of IVIG treatment is associated with therapeutic responsiveness and coronary artery abnormalities but not with clinical classification in the acute episode of Kawasaki disease Samadli, Sama Liu, Fei Fei Mammadov, Goshgar Wang, Jing Jing Liu, Hui Hui Wu, Yang Fang Luo, Huang Huang Wu, Yue Chen, Wei Xia Zhang, Dong Dong Wei, Wei Hu, Peng Pediatr Rheumatol Online J Research Article BACKGROUND: In the last decade, incomplete Kawasaki disease (KD), intravenous immunoglobulin (IVIG) non-response and coronary artery abnormalities (CAA) have experienced the increasing trends in China. In addition, the enhancement of pediatricians’ awareness may also raise the diagnostic rate of incomplete KD and stimulate more aggressive initial therapy in the acute episode of KD. Given this background, we hypothesize that the time option of IVIG treatment should be in parallel with peak time of systemic inflammation; either earlier or later IVIG treatment may affect the clinical classification, therapeutic responsiveness and CAA occurrence in KD patients. Therefore, the major objective of the present study is to identify whether the time option of IVIG treatment could be associated with the clinical classification, therapeutic responsiveness and CAA occurrence in the acute episode of KD. MATERIALS AND METHODS: A total of 153 children with KD were recruited between July 2015 and May 2018. All patients received the standard therapy of KD, including a single infusion of IVIG (2 g/kg) and aspirin (30–50 mg/kg/d). Blood samples were collected from all subjects within 24 h pre-IVIG treatment, respectively. Echocardiography was performed during the period from 2 days to 14 days after IVIG treatment. RESULTS: (1) The clinical classification presented no significant heterogenicity among different treatment time (x(2) = 1.59, p > 0.05) (2) Eleven KD patients resisted to IVIG treatment and 7 of them (63.60%) received the initial IVIG dose on day 5 and 6. (3) The distribution of CAA onset was subjected to a significant difference according to timing option of IVIG treatment (x(2) = 11.94, p < 0.05). CONCLUSIONS: The time option of IVIG treatment is associated with therapeutic responsiveness and CAA but not with clinical classification in the acute episode of KD. BioMed Central 2019-07-31 /pmc/articles/PMC6668082/ /pubmed/31366406 http://dx.doi.org/10.1186/s12969-019-0352-3 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Samadli, Sama Liu, Fei Fei Mammadov, Goshgar Wang, Jing Jing Liu, Hui Hui Wu, Yang Fang Luo, Huang Huang Wu, Yue Chen, Wei Xia Zhang, Dong Dong Wei, Wei Hu, Peng The time option of IVIG treatment is associated with therapeutic responsiveness and coronary artery abnormalities but not with clinical classification in the acute episode of Kawasaki disease |
title | The time option of IVIG treatment is associated with therapeutic responsiveness and coronary artery abnormalities but not with clinical classification in the acute episode of Kawasaki disease |
title_full | The time option of IVIG treatment is associated with therapeutic responsiveness and coronary artery abnormalities but not with clinical classification in the acute episode of Kawasaki disease |
title_fullStr | The time option of IVIG treatment is associated with therapeutic responsiveness and coronary artery abnormalities but not with clinical classification in the acute episode of Kawasaki disease |
title_full_unstemmed | The time option of IVIG treatment is associated with therapeutic responsiveness and coronary artery abnormalities but not with clinical classification in the acute episode of Kawasaki disease |
title_short | The time option of IVIG treatment is associated with therapeutic responsiveness and coronary artery abnormalities but not with clinical classification in the acute episode of Kawasaki disease |
title_sort | time option of ivig treatment is associated with therapeutic responsiveness and coronary artery abnormalities but not with clinical classification in the acute episode of kawasaki disease |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668082/ https://www.ncbi.nlm.nih.gov/pubmed/31366406 http://dx.doi.org/10.1186/s12969-019-0352-3 |
work_keys_str_mv | AT samadlisama thetimeoptionofivigtreatmentisassociatedwiththerapeuticresponsivenessandcoronaryarteryabnormalitiesbutnotwithclinicalclassificationintheacuteepisodeofkawasakidisease AT liufeifei thetimeoptionofivigtreatmentisassociatedwiththerapeuticresponsivenessandcoronaryarteryabnormalitiesbutnotwithclinicalclassificationintheacuteepisodeofkawasakidisease AT mammadovgoshgar thetimeoptionofivigtreatmentisassociatedwiththerapeuticresponsivenessandcoronaryarteryabnormalitiesbutnotwithclinicalclassificationintheacuteepisodeofkawasakidisease AT wangjingjing thetimeoptionofivigtreatmentisassociatedwiththerapeuticresponsivenessandcoronaryarteryabnormalitiesbutnotwithclinicalclassificationintheacuteepisodeofkawasakidisease AT liuhuihui thetimeoptionofivigtreatmentisassociatedwiththerapeuticresponsivenessandcoronaryarteryabnormalitiesbutnotwithclinicalclassificationintheacuteepisodeofkawasakidisease AT wuyangfang thetimeoptionofivigtreatmentisassociatedwiththerapeuticresponsivenessandcoronaryarteryabnormalitiesbutnotwithclinicalclassificationintheacuteepisodeofkawasakidisease AT luohuanghuang thetimeoptionofivigtreatmentisassociatedwiththerapeuticresponsivenessandcoronaryarteryabnormalitiesbutnotwithclinicalclassificationintheacuteepisodeofkawasakidisease AT wuyue thetimeoptionofivigtreatmentisassociatedwiththerapeuticresponsivenessandcoronaryarteryabnormalitiesbutnotwithclinicalclassificationintheacuteepisodeofkawasakidisease AT chenweixia thetimeoptionofivigtreatmentisassociatedwiththerapeuticresponsivenessandcoronaryarteryabnormalitiesbutnotwithclinicalclassificationintheacuteepisodeofkawasakidisease AT zhangdongdong thetimeoptionofivigtreatmentisassociatedwiththerapeuticresponsivenessandcoronaryarteryabnormalitiesbutnotwithclinicalclassificationintheacuteepisodeofkawasakidisease AT weiwei thetimeoptionofivigtreatmentisassociatedwiththerapeuticresponsivenessandcoronaryarteryabnormalitiesbutnotwithclinicalclassificationintheacuteepisodeofkawasakidisease AT hupeng thetimeoptionofivigtreatmentisassociatedwiththerapeuticresponsivenessandcoronaryarteryabnormalitiesbutnotwithclinicalclassificationintheacuteepisodeofkawasakidisease AT samadlisama timeoptionofivigtreatmentisassociatedwiththerapeuticresponsivenessandcoronaryarteryabnormalitiesbutnotwithclinicalclassificationintheacuteepisodeofkawasakidisease AT liufeifei timeoptionofivigtreatmentisassociatedwiththerapeuticresponsivenessandcoronaryarteryabnormalitiesbutnotwithclinicalclassificationintheacuteepisodeofkawasakidisease AT mammadovgoshgar timeoptionofivigtreatmentisassociatedwiththerapeuticresponsivenessandcoronaryarteryabnormalitiesbutnotwithclinicalclassificationintheacuteepisodeofkawasakidisease AT wangjingjing timeoptionofivigtreatmentisassociatedwiththerapeuticresponsivenessandcoronaryarteryabnormalitiesbutnotwithclinicalclassificationintheacuteepisodeofkawasakidisease AT liuhuihui timeoptionofivigtreatmentisassociatedwiththerapeuticresponsivenessandcoronaryarteryabnormalitiesbutnotwithclinicalclassificationintheacuteepisodeofkawasakidisease AT wuyangfang timeoptionofivigtreatmentisassociatedwiththerapeuticresponsivenessandcoronaryarteryabnormalitiesbutnotwithclinicalclassificationintheacuteepisodeofkawasakidisease AT luohuanghuang timeoptionofivigtreatmentisassociatedwiththerapeuticresponsivenessandcoronaryarteryabnormalitiesbutnotwithclinicalclassificationintheacuteepisodeofkawasakidisease AT wuyue timeoptionofivigtreatmentisassociatedwiththerapeuticresponsivenessandcoronaryarteryabnormalitiesbutnotwithclinicalclassificationintheacuteepisodeofkawasakidisease AT chenweixia timeoptionofivigtreatmentisassociatedwiththerapeuticresponsivenessandcoronaryarteryabnormalitiesbutnotwithclinicalclassificationintheacuteepisodeofkawasakidisease AT zhangdongdong timeoptionofivigtreatmentisassociatedwiththerapeuticresponsivenessandcoronaryarteryabnormalitiesbutnotwithclinicalclassificationintheacuteepisodeofkawasakidisease AT weiwei timeoptionofivigtreatmentisassociatedwiththerapeuticresponsivenessandcoronaryarteryabnormalitiesbutnotwithclinicalclassificationintheacuteepisodeofkawasakidisease AT hupeng timeoptionofivigtreatmentisassociatedwiththerapeuticresponsivenessandcoronaryarteryabnormalitiesbutnotwithclinicalclassificationintheacuteepisodeofkawasakidisease |